A heavy burden of family financial stress from COVID on mental health of adolescents Adolescents MentalHealth Stress Coronavirus Disease COVID LancetRH_Americ ChildrensPhila CHOP_Research PennMedicine
Study: COVID-19-related financial strain and adolescent mental health. Image Credit: Astafjeva / Shutterstock
However, the specific impacts of pandemic-related financial stress, changes in familial interactions, and factors such as the mental health of the parents, conflict within the family, and quality of parenting on adolescents' mental health have not been comprehensively investigated. The outcome measures were assessed on an eight-item sadness scale which analyzed feelings of loneliness, sadness, inability to have fun, and despair on a scale of one to five, with one being "never" to five denoting "always." The ABCD study surveys also contained questions that assessed substance use, such as alcohol, marijuana, and other drug use among the participants.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Excess deaths by sex and Age Group in the first two years of the COVID-19 pandemic in the United States - Health Care Management ScienceThe COVID-19 pandemic hastened hundreds of thousands of deaths in the United States. Many of these excess deaths are directly attributed to COVID-19, but others stem from the pandemic’s social, economic, and health care system disruptions. This study compares provisional mortality data for age and sex subgroups across different time windows, with and without COVID-19 deaths, and assesses whether mortality risks are returning to pre-pandemic levels. Using provisional mortality reports from the CDC, we compute mortality risks for 22 age and sex subgroups in 2021 and compare against 2015–2019 using odds ratios. We repeat this comparison for the first twelve full months of the COVID-19 pandemic in the United States (April 2020–March 2021) against the next twelve full months (April 2021–March 2022). Mortality risks for most subgroups were significantly higher in 2021 than in 2015–2019, both with and without deaths involving COVID-19. For ages 25–54, Year 2 (April 2021–March 2022) was more fatal than Year 1 (April 2020–March 2021), whereas total mortality risks for the 65 + age groups declined. Given so many displaced deaths in the first two years of the COVID-19 pandemic, mortality risks in the next few years may fall below pre-pandemic levels. Provisional mortality data suggest this is already happening for the 75 + age groups when excluding COVID-19 deaths.
Read more »
MotoGP Spectators: Germany top, Italy drop, 2.4 million totalAfter two seasons of Covid protocols, spectator restrictions were eased for the 2022 MotoGP World Championship.
Read more »
IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19 - Virology JournalBackground The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19), which is currently a worldwide pandemic. There are limited available treatments for severe COVID-19 patients. However, some evidence suggests that intravenous immunoglobulin (IVIg) provides clinical benefits for these patients. Methods We administered IVIg to 23 severe COVID-19 patients, and all of them survived. Four related coronaviruses can cause the common cold. We speculated that cross-reactivity of SARS-CoV-2 and other common coronaviruses might partially explain the clinical efficacy of IVIg therapy. Thus, we performed multiple alignment analysis of the spike (S), membrane (M), and nucleotide (N) proteins from SARS-CoV-2 and the common coronaviruses to identify conserved regions. Next, we synthesized 25 peptides that were conserved regions and tested their IVIg seropositivity. Results The results indicated four peptides had significant or nearly significant seropositivity, and all of them were associated with the S and M proteins. Examination of the immune responses of healthy volunteers to each synthetic peptide indicated high seropositivity to the two peptides from S protein. Blood samples from healthy individuals may have pre-existing anti-SARS-CoV-2 IgGs, and IVIg is a potentially effective therapy for severe COVID-19. Conclusion In conclusion, blood samples from many healthy individuals have pre-existing anti-SARS-CoV-2 IgGs, and IVIg may be an effective therapy for severe COVID-19.
Read more »
Lancashire GP: How to tell if you have Long Covid and where to get adviceHealth officials in Lancashire and South Cumbria are raising awareness of the symptoms of Long Covid during Self Care Week.
Read more »
What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?Researchers examined the prevalence of contraindications to nirmatrelvir-ritonavir (Paxlovid) in hospitalized coronavirus disease 2019 (COVID-19) patients.
Read more »
Comparing post–COVID-19 symptoms two years after SARS-CoV-2 infectionResearchers compared the presence of post–coronavirus disease 2019 (COVID-19) symptoms among hospitalized and non-hospitalized patients in Spain.
Read more »